Regulon

Regulon: R-3162

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
132.1799919Pr-5Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
1265 ENSG00000064666 CNN2 B4DUT8
2355 ENSG00000075426 FOSL2 P15408
857 ENSG00000105974 CAV1 A0A024R757
5997 ENSG00000116741 RGS2 P41220
22936 ENSG00000118985 ELL2 O00472
3553 ENSG00000125538 IL1B P01584
10457 ENSG00000136235 GPNMB Q14956
3569 ENSG00000136244 IL6 B4DNV3
3586 ENSG00000136634 IL10 P22301
53918 ENSG00000152684 PELO Q9BRX2
1836 ENSG00000155850 SLC26A2 P50443
80176 ENSG00000171621 SPSB1 Q96BD6
5551 ENSG00000180644 PRF1 P14222

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
SCH-708980IL10AntibodyINHIBITORInterleukin-10 inhibitor20
CANAKINUMABIL1BAntibodyINHIBITORInterleukin-1 beta inhibitor40
RILONACEPTIL1BProteinINHIBITORInterleukin-1 beta inhibitor40
MEDI-5117IL6AntibodyINHIBITORInterleukin-6 inhibitor10
GEVOKIZUMABIL1BAntibodyNEGATIVE ALLOSTERIC MODULATORInterleukin-1 beta negative allosteric modulator30
CLAZAKIZUMABIL6AntibodyINHIBITORInterleukin-6 inhibitor30
OLOKIZUMABIL6AntibodyINHIBITORInterleukin-6 inhibitor30
SILTUXIMABIL6AntibodyANTAGONISTInterleukin-6 inhibitor40
MRA 003 USIL6AntibodyINHIBITORInterleukin-6 inhibitor10
LUTIKIZUMABIL1AAntibodyINHIBITORInterleukin-1 beta inhibitor20
PF-04236921IL6AntibodyINHIBITORInterleukin-6 inhibitor20
GLEMBATUMUMAB VEDOTINTUBB1AntibodyBINDING AGENTTransmembrane glycoprotein NMB binding agent20
GLEMBATUMUMABGPNMBAntibodyBINDING AGENTTransmembrane glycoprotein NMB binding agent10
SIRUKUMABIL6AntibodyINHIBITORInterleukin-6 inhibitor30
ZILTIVEKIMABIL6AntibodyBINDING AGENTInterleukin-6 binding agent20

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-3162

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-06379PCDHGA1up-regulatesPBX1repressesR-3162121Drugs (15)
CMF-07016ATRXup-regulatesPBX1repressesR-3162127Drugs (15)
CMF-07837TNK2up-regulatesPBX1repressesR-3162121Drugs (15)
CMF-12727SIN3Aup-regulatesPBX1repressesR-3162123Drugs (15)
CMF-13752SIGLEC6up-regulatesPBX1repressesR-3162121Drugs (15)
CMF-13926HRH2down-regulatesPBX1repressesR-3162124Drugs (15)
CMF-22733IDH1up-regulatesPBX1repressesR-3162129Drugs (15)
CMF-28225REPIN1down-regulatesPBX1repressesR-3162121Drugs (15)
CMF-30640SALL4up-regulatesPBX1repressesR-3162121Drugs (15)